Suchergebnisse - "van der Heijde, Désirée"

PubPharm (84)

1

Anti-GM-CSF otilimab versus tofacitinib or placebo in patients with active rheumatoid arthritis and an inadequate response to conventional or biologic DMARDs : two phase 3 randomised trials (contRAst 1 and contRAst 2)

enthalten in: Annals of the rheumatic diseases | 2023

von Fleischmann, R. | van der Heijde, D. | Strand, V. | +19

2

Discontinuation of Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis and Excellent Disease Control

enthalten in: JAMA | 2023

von Lillegraven, S. | Paulshus Sundlisæter, N. | Aga, A. | +4

ErratumIn: JAMA. 2023 May 9;329(18):1612. - PMID 37159047

3

Efficacy of synthetic and biological DMARDs : a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis

enthalten in: Annals of the rheumatic diseases | 2023

von Kerschbaumer, A. | Sepriano, A. | Bergstra, S. | +14

4

Post hoc analysis of clinical characteristics of patients with radiographic progression in a Japanese phase 3 trial of peficitinib and methotrexate treatment (RAJ4)

enthalten in: Modern rheumatology | 2023

von Tanaka, Y. | Takeuchi, T. | Kato, D. | +5

5

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs : 2022 update

enthalten in: Annals of the rheumatic diseases | 2023

von Smolen, J. | Landewé, R. | Bergstra, S. | +45

ErratumIn: Ann Rheum Dis. 2023 Mar;82(3):e76. - PMID 36764818

6

Radiographic Progression of Structural Joint Damage Over 5 Years of Baricitinib Treatment in Patients With Rheumatoid Arthritis : Results From RA-BEYOND

enthalten in: The Journal of rheumatology | 2022

von van der Heijde, D. | Kartman, C. | Xie, L. | +6

7

Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate : a phase III randomised clinical trial

enthalten in: Annals of the rheumatic diseases | 2021

von Combe, B. | Kivitz, A. | Tanaka, Y. | +17

8

Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate : the phase 3, randomised controlled FINCH 3 trial

enthalten in: Annals of the rheumatic diseases | 2021

von Westhovens, R. | Rigby, W. | van der Heijde, D. | +16

9

Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients With Rheumatoid Arthritis in Remission : The ARCTIC REWIND Randomized Clinical Trial

enthalten in: JAMA | 2021

von Lillegraven, S. | Paulshus Sundlisæter, N. | Aga, A. | +18

CommentIn: JAMA. 2021 Sep 7;326(9):872-873. - PMID 34547087

10

Tofacitinib in combination with methotrexate in patients with rheumatoid arthritis : patient-reported outcomes from the 24-month Phase 3 ORAL Scan study

enthalten in: Clinical and experimental rheumatology | 2020

von Strand, V. | van der Heijde, D. | Tanaka, Y. | +13

1
2
3
4
5
6
7
8
9
Nächster »
[9]